Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced that the U.S. Food and Drug Administration (FDA), has ...
Neurotech’s Encelto is surgically implanted and delivers genetically modified cell therapy to the eye Neurotech Pharmaceuticals Inc.’s research efforts are paying off. The biotech company, focused on ...
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech Pharmaceuticals is on the verge of making its commercial debut. The FDA last week ...
Gene therapy offers one-time treatment, but must also be administered by injection. Neurotech Pharmaceuticals’ gene therapy comes in a surgical implant, and it’s now the first FDA-approved ...
Neurotech Pharmaceuticals Inc., whose executive chairman is well-known Orange County executive Jim Mazzo, announced that it received FDA approval for its treatment of a type of macular telangiectasia ...
Image caption: Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D., will keynote the 2025 Bioelectronic Medicine Forum in New York City on April 10. NEWS SOURCE: Neurotech Reports ...
Image caption: Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D., will keynote the 2025 Bioelectronic Medicine ...
Stockhead on MSN3d
Top of mind: ASX companies tackling neurological disordersSeveral ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback